Market Overview:
The global breast lesion localization methods market reached a value of US$ 987.3 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,856.70 Million by 2027 exhibiting a CAGR of 10.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.
Breast Lesion Localization Methods Market Trends:
A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, usage and end user.
Breakup by Type:
- Wire Localization
- Radioisotope Localization
- Magnetic Tracers Localization
- Others
Breakup by Usage:
- Tumor Identification
- Sentinel Lymph Node Identification
Breakup by End User:
- Hospitals
- Diagnostic Centres
- Oncology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Million |
| Segment Coverage |
Type, Usage, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global breast lesion localization methods market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global breast lesion localization methods market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the usage?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global breast lesion localization methods market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Breast Lesion Localization Methods Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Wire Localization
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Radioisotope Localization
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Magnetic Tracers Localization
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Usage
7.1 Tumor Identification
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Sentinel Lymph Node Identification
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Lumpectomy
7.2.2.2 Mastectomy
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Centres
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Oncology Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Ambulatory Surgical Centers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Argon Medical Devices Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Cook Group Incorporated
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 CP Medical Inc. (Theragenics Corporation)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Endomagnetics Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Hologic Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 IsoAid LLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 IZI Medical Products (Landauer Inc)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Laurane Medical LLC
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Merit Medical Systems Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sterylab S.r.l
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Breast Lesion Localization Methods Market: Major Drivers and Challenges
Figure 2: Global: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Breast Lesion Localization Methods Market: Breakup by Type (in %), 2021
Figure 5: Global: Breast Lesion Localization Methods Market: Breakup by Usage (in %), 2021
Figure 6: Global: Breast Lesion Localization Methods Market: Breakup by End User (in %), 2021
Figure 7: Global: Breast Lesion Localization Methods Market: Breakup by Region (in %), 2021
Figure 8: Global: Breast Lesion Localization Methods (Wire Localization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Breast Lesion Localization Methods (Wire Localization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Breast Lesion Localization Methods (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Breast Lesion Localization Methods (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Breast Lesion Localization Methods (Tumor Identification) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Breast Lesion Localization Methods (Tumor Identification) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Breast Lesion Localization Methods (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Breast Lesion Localization Methods (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Breast Lesion Localization Methods (Oncology Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Breast Lesion Localization Methods (Oncology Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Breast Lesion Localization Methods Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Breast Lesion Localization Methods Industry: SWOT Analysis
Figure 78: Global: Breast Lesion Localization Methods Industry: Value Chain Analysis
Figure 79: Global: Breast Lesion Localization Methods Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Breast Lesion Localization Methods Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Usage (in Million US$), 2022-2027
Table 4: Global: Breast Lesion Localization Methods Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Breast Lesion Localization Methods Market: Competitive Structure
Table 7: Global: Breast Lesion Localization Methods Market: Key Players